Edesa Biotech, Inc. (EDSA)
2.74
-0.08
(-2.84%)
USD |
NASDAQ |
Oct 21, 16:00
2.74
0.00 (0.00%)
After-Hours: 19:15
Edesa Biotech Net Income (Quarterly) : -5.408M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.408M |
| March 31, 2026 | -4.218M |
| December 31, 2025 | -2.248M |
| September 30, 2025 | -2.228M |
| June 30, 2025 | -1.750M |
| March 31, 2025 | -1.590M |
| December 31, 2024 | -1.617M |
| September 30, 2024 | -0.9621M |
| June 30, 2024 | -1.668M |
| March 31, 2024 | -1.861M |
| December 31, 2023 | -1.678M |
| September 30, 2023 | -1.720M |
| June 30, 2023 | -1.985M |
| March 31, 2023 | -2.334M |
| December 31, 2022 | -2.335M |
| September 30, 2022 | -2.814M |
| June 30, 2022 | -5.787M |
| March 31, 2022 | -4.569M |
| December 31, 2021 | -4.379M |
| September 30, 2021 | -3.686M |
| June 30, 2021 | -4.760M |
| March 31, 2021 | -2.26M |
| December 31, 2020 | -2.638M |
| September 30, 2020 | -2.014M |
| June 30, 2020 | -1.766M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.490M |
| December 31, 2019 | -1.094M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -1.656M |
| December 31, 2018 | -1.406M |
| September 30, 2018 | -1.129M |
| June 30, 2018 | -1.157M |
| March 31, 2018 | -1.352M |
| December 31, 2017 | -1.401M |
| September 30, 2017 | -1.221M |
| June 30, 2017 | -1.220M |
| March 31, 2017 | -1.104M |
| December 31, 2016 | -1.486M |
| September 30, 2016 | -1.341M |
| June 30, 2016 | -1.194M |
| March 31, 2016 | -0.861M |
| December 31, 2015 | -1.630M |
| September 30, 2015 | -1.537M |
| June 30, 2015 | 0.464M |
| March 31, 2015 | -0.4262M |
| December 31, 2014 | -1.344M |
| August 31, 2014 | -4.635M |
| May 31, 2014 | 1.813M |
| February 28, 2014 | -0.238M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ProMIS Neurosciences, Inc. | -11.73M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.408M |
| EPS Diluted (Quarterly) | -0.6003 |
| Enterprise Value | 25.25M |
| Earnings Yield | -61.74% |
| Normalized Earnings Yield | -63.47 |